Compendium of Cancer Genome Aberrations

SKIN5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
<br />
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Skin Tumours (5th Edition) Content</big>
Line 17: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|
==== CHAPTER 2 (KERATINOCYTIC/EPIDERMAL TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Actinic_keratosis|Actinic keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Arsenical_keratosis|Arsenical keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:PUVA_keratosis|PUVA keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Squamous_cell_carcinoma_in_situ_(Bowen_disease)|Squamous cell carcinoma in situ (Bowen disease)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Verruca_vulgaris|Verruca vulgaris]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Verruca_plantaris_and_palmaris|Verruca plantaris and palmaris]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Verruca_plana|Verruca plana]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Seborrhoeic_keratosis|Seborrhoeic keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Solar_lentigo|Solar lentigo]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Lichen_planus-like_keratosis|Lichen planus-like keratosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Clear_cell_acanthoma|Clear cell acanthoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Large_cell_acanthoma|Large cell acanthoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Warty_dyskeratoma|Warty dyskeratoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Other_benign_keratoses|Other benign keratoses]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Basal_cell_carcinomas|Basal cell carcinomas]]
|Disease (OVERVIEW?)
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Superficial_basal_cell_carcinoma|Superficial basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Nodular_basal_cell_carcinoma|Nodular basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Micronodular_basal_cell_carcinoma|Micronodular basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Infiltrating_basal_cell_carcinoma|Infiltrating basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Sclerosing/morphoeic_basal_cell_carcinoma|Sclerosing/morphoeic basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Basosquamous_carcinoma|Basosquamous carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Basal_cell_carcinoma_with_sarcomatoid_differentiation|Basal cell carcinoma with sarcomatoid differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Basal_cell_carcinoma_with_adnexal_differentiation|Basal cell carcinoma with adnexal differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibroepithelial_basal_cell_carcinoma|Fibroepithelial basal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Keratoacanthoma|Keratoacanthoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Squamous_cell_carcinomas|Squamous cell carcinomas]]
|Disease (OVERVIEW?)
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Verrucous_squamous_cell_carcinoma|Verrucous squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Acantholytic_squamous_cell_carcinoma|Acantholytic squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Lymphoepithelial_carcinoma|Lymphoepithelial carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Clear_cell_squamous_cell_carcinoma|Clear cell squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Spindle_cell_squamous_cell_carcinoma|Spindle cell squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Squamous_cell_carcinoma_with_sarcomatoid_differentiation|Squamous cell carcinoma with sarcomatoid differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 3 (MELANOCYTIC TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Junctional,_compound,_and_dermal_naevi|Junctional, compound, and dermal naevi]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Simple_lentigo_and_lentiginous_melanocytic_naevus|Simple lentigo and lentiginous melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dysplastic_naevus|Dysplastic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Naevus_spilus|Naevus spilus]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[SKIN5:Special-site_naevi_(of_the_breast,_axilla,_scalp,_and_ear)|Special-site naevi (of the breast, axilla, scalp, and ear)]]
|Disease
|
|
|
|
|
Line 27: Line 479:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Halo_naevus|Halo naevus]]
|Disease
|
|
|
|
|
Line 36: Line 490:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Meyerson_naevus|Meyerson naevus]]
|Disease
|
|
|
|
|
Line 45: Line 501:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Recurrent_naevus|Recurrent naevus]]
|Disease
|
|
|
|
|
Line 54: Line 512:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Combined_naevus|Combined naevus]]
|Disease
|
|
|
|
|
Line 63: Line 523:
|
|
|-
|-
| ||Disease||
|[[SKIN5:WNT-activated_deep_penetrating/plexiform_melanocytoma_(naevus)|WNT-activated deep penetrating/plexiform melanocytoma (naevus)]]
|Disease
|
|
|
|
|
Line 72: Line 534:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Pigmented_epithelioid_melanocytoma|Pigmented epithelioid melanocytoma]]
|Disease
|
|
|
|
|
Line 81: Line 545:
|
|
|-
|-
| ||Disease||
|[[SKIN5:BAP1-inactivated_melanocytoma|BAP1-inactivated melanocytoma]]
|Disease
|
|
|
|
|
Line 90: Line 556:
|
|
|-
|-
| ||Disease||
|[[SKIN5:MITF_pathway-activated_melanocytic_tumours|MITF pathway-activated melanocytic tumours]]
|Disease
|
|
|
|
|
Line 99: Line 567:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Low-CSD_melanoma_(including_superficial_spreading_melanoma)|Low-CSD melanoma (including superficial spreading melanoma)]]
|Disease
|
|
|
|
|
Line 108: Line 578:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Lentigo_maligna_melanoma|Lentigo maligna melanoma]]
|Disease
|
|
|
|
|
Line 117: Line 589:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Desmoplastic_melanoma|Desmoplastic melanoma]]
|Disease
|
|
|
|
|
Line 126: Line 600:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Pigmented_spindle_cell_naevus_(Reed_naevus)|Pigmented spindle cell naevus (Reed naevus)]]
|Disease
|
|
|
|
|
Line 135: Line 611:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Spitz_naevus|Spitz naevus]]
|Disease
|
|
|
|
|
Line 144: Line 622:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Spitz_melanocytoma_(Atypical_Spitz_tumour)|Spitz melanocytoma (Atypical Spitz tumour)]]
|Disease
|
|
|
|
|
Line 153: Line 633:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Spitz_melanoma|Spitz melanoma]]
|Disease
|
|
|
|
|
Line 162: Line 644:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Acral_naevus|Acral naevus]]
|Disease
|
|
|
|
|
Line 171: Line 655:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Acral_melanoma|Acral melanoma]]
|Disease
|
|
|
|
|
Line 180: Line 666:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Melanosis|Melanosis]]
|Disease
|
|
|
|
|
Line 189: Line 677:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Genital_naevus|Genital naevus]]
|Disease
|
|
|
|
|
Line 198: Line 688:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Mucosal_melanomas|Mucosal melanomas]]
|Disease
|
|
|
|
|
Line 207: Line 699:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Naevus_of_Ito_and_naevus_of_Ota|Naevus of Ito and naevus of Ota]]
|Disease
|
|
|
|
|
Line 216: Line 710:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Congenital_dermal_melanocytosis|Congenital dermal melanocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Blue_naevus|Blue naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Melanoma_arising_in_blue_naevus|Melanoma arising in blue naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Congenital_melanocytic_naevus|Congenital melanocytic naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Proliferative_nodules_in_congenital_melanocytic_naevus|Proliferative nodules in congenital melanocytic naevus]]
|Disease
|
|
|
|
|
Line 225: Line 765:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Melanoma_arising_in_giant_congenital_naevus|Melanoma arising in giant congenital naevus]]
|Disease
|
|
|
|
|
Line 234: Line 776:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Conjunctival_naevus|Conjunctival naevus]]
|Disease
|
|
|
|
|
Line 243: Line 787:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Conjunctival_melanocytic_intraepithelial_lesions|Conjunctival melanocytic intraepithelial lesions]]
|Disease
|
|
|
|
|
Line 252: Line 798:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Conjunctival_melanoma|Conjunctival melanoma]]
|Disease
|
|
|
|
|
Line 261: Line 809:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Uveal_melanocytoma|Uveal melanocytoma]]
|Disease
|
|
|
|
|
Line 270: Line 820:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Uveal_melanoma|Uveal melanoma]]
|Disease
|
|
|
|
|
Line 279: Line 831:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Diffuse_meningeal_melanocytic_neoplasms:_melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
Line 288: Line 842:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Circumscribed_meningeal_melanocytic_neoplasms:_melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: melanocytoma and melanoma]]
|Disease
|
|
|
|
|
Line 297: Line 853:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Nodular_melanoma|Nodular melanoma]]
|Disease
|
|
|
|
|
Line 306: Line 864:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Naevoid_melanoma|Naevoid melanoma]]
|Disease
|
|
|
|
|
Line 315: Line 875:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Dermal_melanoma|Dermal melanoma]]
|Disease
|
|
|
|
|
Line 324: Line 886:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Melanoma_metastatic_to_the_skin|Melanoma metastatic to the skin]]
|Disease
|
|
|
|
|
Line 333: Line 897:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Melanoma_metastatic_to_other_organs|Melanoma metastatic to other organs]]
|Disease
|
|
|
|
|
Line 342: Line 908:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 4 (APPENDAGEAL TUMOURS) ====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
| ||Disease||
|[[SKIN5:Hidrocystoma/cystadenoma|Hidrocystoma/cystadenoma]]
|Disease
|
|
|
|
|
Line 360: Line 940:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Syringoma|Syringoma]]
|Disease
|
|
|
|
|
Line 369: Line 951:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Poroma|Poroma]]
|Disease
|
|
|
|
|
Line 378: Line 962:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Syringofibroadenoma|Syringofibroadenoma]]
|Disease
|
|
|
|
|
Line 387: Line 973:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Hidradenoma|Hidradenoma]]
|Disease
|
|
|
|
|
Line 396: Line 984:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Spiradenoma|Spiradenoma]]
|Disease
|
|
|
|
|
Line 405: Line 995:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Cylindroma|Cylindroma]]
|Disease
|
|
|
|
|
Line 414: Line 1,006:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Tubular_adenoma|Tubular adenoma]]
|Disease
|
|
|
|
|
Line 423: Line 1,017:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Syringocystadenoma_papilliferum|Syringocystadenoma papilliferum]]
|Disease
|
|
|
|
|
Line 432: Line 1,028:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Mixed_tumour|Mixed tumour]]
|Disease
|
|
|
|
|
Line 441: Line 1,039:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Myoepithelioma|Myoepithelioma]]
|Disease
|
|
|
|
|
Line 450: Line 1,050:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Adnexal_adenocarcinoma,_NOS|Adnexal adenocarcinoma, NOS]]
|Disease
|
|
|
|
|
Line 459: Line 1,061:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Microcystic_adnexal_carcinoma|Microcystic adnexal carcinoma]]
|Disease
|
|
|
|
|
Line 468: Line 1,072:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Cribriform_tumour_(previously_carcinoma)|Cribriform tumour (previously carcinoma)]]
|Disease
|
|
|
|
|
Line 477: Line 1,083:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Porocarcinoma|Porocarcinoma]]
|Disease
|
|
|
|
|
Line 486: Line 1,094:
|
|
|-
|-
| ||Disease||
|[[SKIN5:NUT_carcinoma|NUT carcinoma]]
|Disease
|
|
|
|
|
Line 495: Line 1,105:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Malignant_neoplasms_arising_from_spiradenoma,_cylindroma,_or_spiradenocylindroma|Malignant neoplasms arising from spiradenoma, cylindroma, or spiradenocylindroma]]
|Disease
|
|
|
|
|
Line 504: Line 1,116:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Malignant_mixed_tumour|Malignant mixed tumour]]
|Disease
|
|
|
|
|
Line 513: Line 1,127:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Hidradenocarcinoma|Hidradenocarcinoma]]
|Disease
|
|
|
|
|
Line 522: Line 1,138:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Endocrine_mucin-producing_sweat_gland_carcinoma|Endocrine mucin-producing sweat gland carcinoma]]
|Disease
|
|
|
|
|
Line 531: Line 1,149:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Mucinous_carcinoma|Mucinous carcinoma]]
|Disease
|
|
|
|
|
Line 540: Line 1,160:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Digital_papillary_adenocarcinoma|Digital papillary adenocarcinoma]]
|Disease
|
|
|
|
|
Line 549: Line 1,171:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
|Disease
|
|
|
|
|
Line 558: Line 1,182:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Apocrine_carcinoma|Apocrine carcinoma]]
|Disease
|
|
|
|
|
Line 567: Line 1,193:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Squamoid_ductal_eccrine_carcinoma|Squamoid ductal eccrine carcinoma]]
|Disease
|
|
|
|
|
Line 576: Line 1,204:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Syringocystadenocarcinoma_papilliferum|Syringocystadenocarcinoma papilliferum]]
|Disease
|
|
|
|
|
Line 585: Line 1,215:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Secretory_carcinoma|Secretory carcinoma]]
|Disease
|
|
|
|
|
Line 594: Line 1,226:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Signet-ring_cell/histiocytoid_carcinoma|Signet-ring cell/histiocytoid carcinoma]]
|Disease
|
|
|
|
|
Line 603: Line 1,237:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichoblastoma|Trichoblastoma]]
|Disease
|
|
|
|
|
Line 612: Line 1,248:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Pilomatricoma|Pilomatricoma]]
|Disease
|
|
|
|
|
Line 621: Line 1,259:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Melanocytic_matricoma|Melanocytic matricoma]]
|Disease
|
|
|
|
|
Line 630: Line 1,270:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichilemmoma|Trichilemmoma]]
|Disease
|
|
|
|
|
Line 639: Line 1,281:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichoadenoma|Trichoadenoma]]
|Disease
|
|
|
|
|
Line 648: Line 1,292:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichofolliculoma|Trichofolliculoma]]
|Disease
|
|
|
|
|
Line 657: Line 1,303:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Pilar_sheath_acanthoma|Pilar sheath acanthoma]]
|Disease
|
|
|
|
|
Line 666: Line 1,314:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Tumour_of_the_follicular_infundibulum|Tumour of the follicular infundibulum]]
|Disease
|
|
|
|
|
Line 675: Line 1,325:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichodiscomas_and_fibrofolliculomas|Trichodiscomas and fibrofolliculomas]]
|Disease
|
|
|
|
|
Line 684: Line 1,336:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Proliferating_trichilemmal_tumour|Proliferating trichilemmal tumour]]
|Disease
|
|
|
|
|
Line 693: Line 1,347:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Pilomatrical_carcinoma|Pilomatrical carcinoma]]
|Disease
|
|
|
|
|
Line 702: Line 1,358:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichoblastic_carcinoma/carcinosarcoma|Trichoblastic carcinoma/carcinosarcoma]]
|Disease
|
|
|
|
|
Line 711: Line 1,369:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Trichilemmal_carcinoma|Trichilemmal carcinoma]]
|Disease
|
|
|
|
|
Line 720: Line 1,380:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Sebaceoma|Sebaceoma]]
|Disease
|
|
|
|
|
Line 729: Line 1,391:
|
|
|-
|-
| ||Disease||
|[[SKIN5:Sebaceous_adenoma|Sebaceous adenoma]]
|Disease
|
|
|
|
|
Line 738: Line 1,402:
|
|
|-
|-
|[[SKIN5:Sebaceous_carcinoma|Sebaceous carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Hidradenoma_papilliferum|Hidradenoma papilliferum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibroadenoma_and_phyllodes_tumour_of_anogenital_mammary-like_glands|Fibroadenoma and phyllodes tumour of anogenital mammary-like glands]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Mammary_Paget_disease|Mammary Paget disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Extramammary_Paget_disease|Extramammary Paget disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Adenocarcinoma_of_mammary-gland_type|Adenocarcinoma of mammary-gland type]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 5 (TUMOURS OF THE NAIL UNIT) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Onychomatricoma|Onychomatricoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Onychopapilloma|Onychopapilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Ungual_fibrokeratoma|Ungual fibrokeratoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Onychocytic_matricoma|Onychocytic matricoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Subungual_keratoacathoma|Subungual keratoacathoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 6 (TUMOURS OF HAEMATOPOIETIC AND LYMPHOID ORIGIN) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Mastocytosis|Mastocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Mast_cell_sarcoma|Mast cell sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cutaneous_involvement_in_myeloid_neoplasms,_including_myeloid_sarcoma|Cutaneous involvement in myeloid neoplasms, including myeloid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Mature_plasmacytoid_dendritic_cell_proliferation_associated_with_myeloid_neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Blastic_plasmacytoid_dendritic_cell_neoplasm|Blastic plasmacytoid dendritic cell neoplasm]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Xanthelasma|Xanthelasma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Reticulohistiocytosis|Reticulohistiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Rosai-Dorfman_Disease|Rosai-Dorfman Disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:ALK_postive_histiocytosis_|ALK postive histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Indeterminate_dendritic_cell_tumour|Indeterminate dendritic cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Reactive_B-cell_rich_lymphoid_proliferations|Reactive B-cell rich lymphoid proliferations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_marginal_zone_lymphoma|Primary cutaneous marginal zone lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_follicle_centre_lymphoma|Primary cutaneous follicle centre lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Mantle_cell_lymphoma|Mantle cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Burkitt_lymphoma|Burkitt lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Chronic_lymphocytic_leukaemia/small_lymphocytic_lymphoma|Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:B-lymphoblastic_leukaemia/lymphoma|B-lymphoblastic leukaemia/lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Secondary_lymphomatoid_granulomatosis_|Secondary lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Reactive_T-cell_rich_lymphoid_proliferations|Reactive T-cell rich lymphoid proliferations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_CD4-positive_small_or_medium_T-cell_lymphoproliferative_disorder|Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Mycosis_fungoides|Mycosis fungoides]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Lymphomatoid_papulosis|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_CD30+_T-cell_lymphoproliferative_disorder:_Primary_cutaneous_anaplastic_large_cell_lymphoma|Primary cutaneous CD30+ T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Subcutaneous_panniculitis-like_T-cell_lymphoma|Subcutaneous panniculitis-like T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_gamma/delta_T-cell_lymphoma|Primary cutaneous gamma/delta T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_acral_CD8-positive_T-cell_lymphoproliferative_disorder|Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_CD8-positive_aggressive_epidermotropic_cytotoxic_T-cell_lymphoma|Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Primary_cutaneous_peripheral_T-cell_lymphoma,_NOS|Primary cutaneous peripheral T-cell lymphoma, NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Sezary_syndrome|Sezary syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Severe_mosquito_bite_allergy|Severe mosquito bite allergy]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Hydroa_vacciniforme_lymphoproliferative_disorder|Hydroa vacciniforme lymphoproliferative disorder]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Anaplastic_large_cell_lymphoma|Anaplastic large cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Nodal_T_follicular_helper_lymphoma,_angioimmunoblastic_type|Nodal T follicular helper lymphoma, angioimmunoblastic type]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:T-cell_prolymphocytic_leukaemia|T-cell prolymphocytic leukaemia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:T-lymphoblastic_leukaemia/lymphoma|T-lymphoblastic leukaemia/lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Adult_T_cell_leukaemia/lymphoma|Adult T cell leukaemia/lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Extranodal_NK/T-cell_lymphoma|Extranodal NK/T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:EBV-positive_mucocutaneous_ulcer|EBV-positive mucocutaneous ulcer]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Inborn_error_of_immunity-associated_lymphoproliferative_disorders|Inborn error of immunity-associated lymphoproliferative disorders]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 7 (SOFT TISSUE TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Naevus_lipomatosus_superficialis|Naevus lipomatosus superficialis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Lipoma|Lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Angiolipoma|Angiolipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Spindle_cell/pleomorphic_lipoma|Spindle cell/pleomorphic lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Atypical_lipomatous_tumour|Atypical lipomatous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Pleomorphic_liposarcoma|Pleomorphic liposarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Sclerotic_fibroma|Sclerotic fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Gardner_fibroma|Gardner fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Pleomorphic_fibroma|Pleomorphic fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Elastofibroma|Elastofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibrous_papule|Fibrous papule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibroblastic_connective_tissue_naevus|Fibroblastic connective tissue naevus]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Fibroosseous_tumour_of_digits|Fibroosseous tumour of digits]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermatofibroma_(fibrous_histiocytoma)|Dermatofibroma (fibrous histiocytoma)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Superficial_fibromatosis|Superficial fibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Inclusion_body_fibromatosis_|Inclusion body fibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Superficial_acral_fibromyxoma|Superficial acral fibromyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cutaneous_myxoma_(superficial_angiomyxoma)|Cutaneous myxoma (superficial angiomyxoma)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermatomyofibroma|Dermatomyofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Multinucleate_cell_angiohistiocytoma|Multinucleate cell angiohistiocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Plaque-like_CD34+_dermal_fibroma|Plaque-like CD34+ dermal fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Nodular_fasciitis|Nodular fasciitis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:EWSR1::SMAD3_rearranged_fibroblastic_tumour|EWSR1::SMAD3 rearranged fibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cherry_haemangioma|Cherry haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Sinusoidal_haemangioma|Sinusoidal haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Microvenular_haemangioma|Microvenular haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Hobnail_haemangioma|Hobnail haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Glomeruloid_haemangioma|Glomeruloid haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Papillary_haemangioma|Papillary haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Spindle_cell_haemangioma|Spindle cell haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Tufted_haemangioma|Tufted haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Angiokeratoma|Angiokeratoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Infantile_haemangioma|Infantile haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Congenital_non-progressive_haemangiomas:_rapidly_involuting_congenital_haemangioma_and_non-involuting_congenital_haemangioma|Congenital non-progressive haemangiomas: rapidly involuting congenital haemangioma and non-involuting congenital haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Lobular_capillary_haemangioma|Lobular capillary haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Poikilodermatous_plaque-like_haemangioma|Poikilodermatous plaque-like haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Acquired_elastotic_haemangioma|Acquired elastotic haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Verrucous_venous_malformation|Verrucous venous malformation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Arteriovenous_malformation|Arteriovenous malformation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Lymphangioma_(superficial_lymphatic_malformation)|Lymphangioma (superficial lymphatic malformation)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cutaneous_epithelioid_angiomatous_nodule|Cutaneous epithelioid angiomatous nodule]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Post-radiation_atypical_vascular_lesion|Post-radiation atypical vascular lesion]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Hobnail_haemangioendotheliomas|Hobnail haemangioendotheliomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cutaneous_angiosarcoma|Cutaneous angiosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Glomus_tumour|Glomus tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Myopericytoma|Myopericytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Myofibroma_and_myofibromatosis|Myofibroma and myofibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Smooth_muscle_hamartoma|Smooth muscle hamartoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cutaneous_leiomyomas|Cutaneous leiomyomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Atypical_intradermal_smooth_muscle_neoplasm|Atypical intradermal smooth muscle neoplasm]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermal_hyperneury/Epithelial_sheath_neuroma|Dermal hyperneury/Epithelial sheath neuroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Perineurioma|Perineurioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Hybrid_nerve_sheath_tumours_|Hybrid nerve sheath tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cellular_neurothekeoma|Cellular neurothekeoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Epithelioid_fibrous_histiocytoma|Epithelioid fibrous histiocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Non-neural_granular_cell_tumour|Non-neural granular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:PEComa_|PEComa]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Angiomatoid_fibrous_histiocytoma_|Angiomatoid fibrous histiocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:NTRK-rearranged_spindle_cell_neoplasm|NTRK-rearranged spindle cell neoplasm]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Superficial_CD34+_fibroblastic_tumour|Superficial CD34+ fibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Pleomorphic_dermal_sarcoma|Pleomorphic dermal sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:CRTC1::TRIM11_cutaneous_tumour|CRTC1::TRIM11 cutaneous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Dermal_clear_cell_sarcoma|Dermal clear cell sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 8 (METASTASES TO SKIN) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Metastases_to_skin|Metastases to skin]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Cancer_of_unknown_primary_site|Cancer of unknown primary site]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 9 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH SKIN  MALIGNANCIES) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[SKIN5:Familial_melanoma|Familial melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Xeroderma_pigmentosum|Xeroderma pigmentosum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Naevoid_basal_cell_carcinoma_syndrome_(Gorlin_syndrome)|Naevoid basal cell carcinoma syndrome (Gorlin syndrome)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Muir-Torre_syndrome|Muir-Torre syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[SKIN5:Brooke-Spiegler_and_related_syndromes|Brooke-Spiegler and related syndromes]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/SKIN5:Volunteer_Assignments_and_Opportunities"